|1.||Zamponi, Gerald W: 13 articles (10/2015 - 01/2004)|
|2.||Saruta, Takao: 11 articles (10/2015 - 01/2006)|
|3.||Ogihara, Toshio: 11 articles (10/2015 - 02/2004)|
|4.||Dickenson, Anthony H: 11 articles (06/2015 - 01/2002)|
|5.||Lang, Bethan: 11 articles (02/2015 - 05/2002)|
|6.||Ogawa, Hisao: 10 articles (10/2015 - 10/2006)|
|7.||Davis, Barry R: 10 articles (11/2014 - 02/2006)|
|8.||van den Maagdenberg, Arn M J M: 9 articles (08/2015 - 06/2002)|
|9.||Luo, Z David: 9 articles (03/2014 - 09/2004)|
|10.||Ferrari, Michel D: 8 articles (08/2015 - 06/2002)|
|1.||Hypertension (High Blood Pressure)
10/01/1996 - "A calcium channel blocker may be beneficial in a patient with hypertension and concomitant angina. "
01/01/2003 - "Calcium channel antagonists have been shown in large clinical trials to be both safe and effective in controlling blood pressure in diabetic patients and will continue to play a major role in the management of hypertension in this population, particularly in the combination therapy that these patients usually require."
01/01/2015 - "Calcium channel blocker drugs have been shown to be effective in any age group for the management of hypertension, and are safe in the elderly patients. "
08/01/2015 - "In the present study, we investigated the effects of a calcium channel blocker (CCB) and an angiotensin II receptor blocker (ARB) on bone metabolism in elderly bedridden women with hypertension and disuse syndrome. "
01/01/2013 - "The result of this study showed that thiazide diuretic followed by calcium channel blocker could be a feasible strategy in order to ensure that patients in Nigeria with hypertension are better controlled."
08/01/1985 - "Thus, calcium channel blocker therapy appears to be beneficial in controlling angina and improving exercise tolerance in patients with angina pectoris resulting from abnormally small coronary arteries and limited vasodilator reserve.(ABSTRACT TRUNCATED AT 250 WORDS)"
08/01/1985 - "Efficacy of calcium channel blocker therapy for angina pectoris resulting from small-vessel coronary artery disease and abnormal vasodilator reserve."
08/01/1985 - "To assess the effect of calcium channel blocking agents on symptoms and exercise capacity, 26 patients shown to have angina pectoris because of abnormally small coronary arteries and limited vasodilator reserve underwent randomized, double-blind, placebo-controlled outpatient study, with 1 month for each period. "
01/01/2007 - "Calcium channel (Ca) blockers are used as the first choice and effective agents for vasospastic angina pectoris. "
01/01/2003 - "Drug treatment of stable angina pectoris in the elderly: defining the place of calcium channel antagonists."
10/01/2011 - "Use of a high dose of a calcium channel blocker alone or in combination with other agents is therefore likely to be particularly effective in prevention of stroke."
03/01/2000 - "Pharmacologic interventions that involve thrombolysis, calcium channel blockade, and cell membrane receptor antagonism have been studied and have been found to be beneficial in animal cortical stroke models. "
01/01/2002 - "There is a slight tendency for the calcium channel antagonists to be more effective than other drug types in preventing stroke, but slightly less effective in preventing coronary events. "
09/01/1995 - "Data from several different studies now indicate that the neuronal calcium channel antagonists are a promising therapy for the postischemic treatment of stroke."
01/01/1991 - "We analyzed reasons why subjects failed to complete two similar acute stroke trials of calcium-channel antagonists. "
02/15/1986 - "These findings are compared with earlier studies of the protective effects of calcium channel blocking agents in cardiac ischemia."
04/20/2001 - "In the present study, we have examined the expression of voltage-gated calcium channels in a rat model of transient focal ischemia using immunohistochemistry. "
01/01/1998 - "The purpose of this study was to determine the contributions of the excitotoxic mechanism and of calcium channel activation to metabolic and functional damage to rabbit spinal cord after ischemia induced by occlusion of the abdominal aorta. "
06/15/2014 - "Intracellular Mg(2+), which is implicated in arrhythmogenesis and transient cardiac ischemia, inhibits L-type Ca(2+) calcium channel current (ICaL) of adult cardiomyocytes (CMs). "
10/01/2006 - "Initial reduction of NE release may be mediated by an impairment of axonal conduction and/or NE release function, while in the later phase, the skeletal muscle ischemia-induced NE release was partly attributable to exocytosis via intracellular Ca(2+) overload rather than opening of calcium channels or carrier mediated outward transport of NE."
05/15/2001 - "The importance of voltage-dependent Ca2+ channels (VDCCs) in pain transmission has been noticed gradually, as several VDCC blockers have been shown to be effective in inhibiting this process. "
08/01/1990 - "Although the pathophysiologic disturbances leading to vasospasm are not clear, blockade of slow calcium channels is also effective for the treatment of Raynaud's phenomenon, reducing attack frequency, digital pain, and functional disability in many patients, particularly those with primary Raynaud's phenomenon."
10/01/2015 - "Preclinical studies with ABT-639, a peripherally acting highly selective T-type Cav3.2 calcium channel blocker, showed dose-dependent reduction of pain in multiple pain models. "
03/01/2011 - "In vivo electrophysiological studies demonstrate the distinct and predominant functions of voltage-dependent calcium channel subtypes for spinal long-term potentiation and chronic pain."
11/15/2008 - "Here we study the analgesic potential of Ph alpha 1beta, a calcium channel blocker, in rodent models of acute and persistent pain. "
|5.||Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)
|8.||Angiotensin Receptors (Angiotensin II Receptor)
|1.||Drug Therapy (Chemotherapy)
|2.||Cardiopulmonary Bypass (Heart-Lung Bypass)
|5.||Transplantation (Transplant Recipients)